Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

A nutrient-rich diet improved skin and hair health in stressed rats.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Ringworm in pets is influenced by fungi type, immune status, and stress hormones.

Some breast cancer chemotherapy can cause permanent hair loss.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Spironolactone can reduce hair growth in women with hirsutism.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.